Companies/US/DNLI

DENALI THERAPEUTICS INC.

Revenue mix

2023-12-31 · 10-K · USD
By activity
By activity$296M
  • ATVAbeta Option Material Right$294M99.5%
  • Option Services$2M0.6%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).159.8MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).155.1M